These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
858 related articles for article (PubMed ID: 32384820)
1. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. Crawford KHD; Eguia R; Dingens AS; Loes AN; Malone KD; Wolf CR; Chu HY; Tortorici MA; Veesler D; Murphy M; Pettie D; King NP; Balazs AB; Bloom JD Viruses; 2020 May; 12(5):. PubMed ID: 32384820 [TBL] [Abstract][Full Text] [Related]
2. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays. Hyseni I; Molesti E; Benincasa L; Piu P; Casa E; Temperton NJ; Manenti A; Montomoli E Viruses; 2020 Sep; 12(9):. PubMed ID: 32927639 [TBL] [Abstract][Full Text] [Related]
4. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Case JB; Rothlauf PW; Chen RE; Liu Z; Zhao H; Kim AS; Bloyet LM; Zeng Q; Tahan S; Droit L; Ilagan MXG; Tartell MA; Amarasinghe G; Henderson JP; Miersch S; Ustav M; Sidhu S; Virgin HW; Wang D; Ding S; Corti D; Theel ES; Fremont DH; Diamond MS; Whelan SPJ Cell Host Microbe; 2020 Sep; 28(3):475-485.e5. PubMed ID: 32735849 [TBL] [Abstract][Full Text] [Related]
5. Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Zheng Y; Larragoite ET; Williams ESCP; Lama J; Cisneros I; Delgado JC; Slev P; Rychert J; Innis EA; Coiras M; Rondina MT; Spivak AM; Planelles V Virol J; 2021 Jan; 18(1):1. PubMed ID: 33397387 [TBL] [Abstract][Full Text] [Related]
6. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Meyrath M; Szpakowska M; Plesseria JM; Domingues O; Langlet J; Weber B; Krüger R; Ollert M; Chevigné A; Methods Enzymol; 2022; 675():351-381. PubMed ID: 36220277 [TBL] [Abstract][Full Text] [Related]
7. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2. Neerukonda SN; Vassell R; Herrup R; Liu S; Wang T; Takeda K; Yang Y; Lin TL; Wang W; Weiss CD PLoS One; 2021; 16(3):e0248348. PubMed ID: 33690649 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994 [TBL] [Abstract][Full Text] [Related]
10. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700 [TBL] [Abstract][Full Text] [Related]
11. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization. Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832 [TBL] [Abstract][Full Text] [Related]
12. Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice. Liu X; Drelich A; Li W; Chen C; Sun Z; Shi M; Adams C; Mellors JW; Tseng CT; Dimitrov DS Vaccine; 2020 Oct; 38(46):7205-7212. PubMed ID: 33010978 [TBL] [Abstract][Full Text] [Related]